Page last updated: 2024-08-18

acrolein and Fetal Hypoxia

acrolein has been researched along with Fetal Hypoxia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abdel-Moneim, A; AbdElgawad, H; Abdul-Hamid, M; Beemster, GTS; El-Twab, SA; Hosni, A; Prinsen, E	1

Other Studies

1 other study(ies) available for acrolein and Fetal Hypoxia

Article	Year
Cinnamaldehyde mitigates placental vascular dysfunction of gestational diabetes and protects from the associated fetal hypoxia by modulating placental angiogenesis, metabolic activity and oxidative stress. Pharmacological research, 2021, Volume: 165 Topics: Acrolein; Animals; Blood Glucose; Diabetes, Gestational; Energy Metabolism; Female; Fetal Hypoxia; Neovascularization, Pathologic; Oxidative Stress; Placenta; Pregnancy; Rats; Rats, Wistar	2021

Article

Year

Cinnamaldehyde mitigates placental vascular dysfunction of gestational diabetes and protects from the associated fetal hypoxia by modulating placental angiogenesis, metabolic activity and oxidative stress.

Pharmacological research, 2021, Volume: 165

Topics: Acrolein; Animals; Blood Glucose; Diabetes, Gestational; Energy Metabolism; Female; Fetal Hypoxia; Neovascularization, Pathologic; Oxidative Stress; Placenta; Pregnancy; Rats; Rats, Wistar

2021